Sara E. Cosgrove

39.4k total citations · 11 hit papers
290 papers, 23.5k citations indexed

About

Sara E. Cosgrove is a scholar working on Applied Microbiology and Biotechnology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Sara E. Cosgrove has authored 290 papers receiving a total of 23.5k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Applied Microbiology and Biotechnology, 105 papers in Epidemiology and 86 papers in Infectious Diseases. Recurrent topics in Sara E. Cosgrove's work include Antibiotic Use and Resistance (110 papers), Bacterial Identification and Susceptibility Testing (76 papers) and Antimicrobial Resistance in Staphylococcus (54 papers). Sara E. Cosgrove is often cited by papers focused on Antibiotic Use and Resistance (110 papers), Bacterial Identification and Susceptibility Testing (76 papers) and Antimicrobial Resistance in Staphylococcus (54 papers). Sara E. Cosgrove collaborates with scholars based in United States, Israel and Switzerland. Sara E. Cosgrove's co-authors include Adolf W. Karchmer, Pranita D. Tamma, Yehuda Carmeli, Eli N. Perencevich, Lisa L. Maragakis, Donald P. Levine, Henry F. Chambers, Michael J. Rybak, David A. Talan and Barbara E. Murray and has published in prestigious journals such as New England Journal of Medicine, JAMA and Nature Medicine.

In The Last Decade

Sara E. Cosgrove

271 papers receiving 22.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

2011 3.1k citations Sara E. Cosgrove et al. Clinical Infectious Diseases profile →
An Intervention to Decrease Catheter-Related Bloodstream Infections in the ICU

2006 2.8k citations Sara E. Cosgrove et al. profile →
Comparison of Mortality Associated with Methicillin‐Resistant and Methicillin‐SusceptibleStaphylococcus aureusBacteremia: A Meta‐analysis

2003 1.5k citations Sara E. Cosgrove et al. Clinical Infectious Diseases profile →
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary

2011 1.2k citations Sara E. Cosgrove et al. Clinical Infectious Diseases profile →
The Relationship between Antimicrobial Resistance and Patient Outcomes: Mortality, Length of Hospital Stay, and Health Care Costs

2005 917 citations Sara E. Cosgrove Clinical Infectious Diseases profile →
Adverse Clinical and Economic Outcomes Attributable to Methicillin Resistance among Patients withStaphylococcus aureusSurgical Site Infection

2003 723 citations Sara E. Cosgrove et al. Clinical Infectious Diseases profile →
The Impact of Methicillin Resistance in Staphylococcus aureus Bacteremia on Patient Outcomes: Mortality, Length of Stay, and Hospital Charges

2005 709 citations Sara E. Cosgrove et al. Infection Control and Hospital Epidemiology profile →
Combination Therapy for Treatment of Infections with Gram-Negative Bacteria

2012 626 citations Pranita D. Tamma, Sara E. Cosgrove et al. profile →
Association of Adverse Events With Antibiotic Use in Hospitalized Patients

2017 472 citations Pranita D. Tamma, Kathryn Dzintars et al. profile →
Sustaining reductions in catheter related bloodstream infections in Michigan intensive care units: observational study

2010 368 citations Sara E. Cosgrove, Jill A. Marsteller et al. profile →
Prospective, multi-site study of patient outcomes after implementation of the TREWS machine learning-based early warning system for sepsis

2022 156 citations Sara E. Cosgrove, Eili Klein et al. profile →

Peers

Countries citing papers authored by Sara E. Cosgrove

Since Specialization

Citations

This map shows the geographic impact of Sara E. Cosgrove's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara E. Cosgrove with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara E. Cosgrove more than expected).

Fields of papers citing papers by Sara E. Cosgrove

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara E. Cosgrove. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara E. Cosgrove. The network helps show where Sara E. Cosgrove may publish in the future.

Co-authorship network of co-authors of Sara E. Cosgrove

This figure shows the co-authorship network connecting the top 25 collaborators of Sara E. Cosgrove. A scholar is included among the top collaborators of Sara E. Cosgrove based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara E. Cosgrove. Sara E. Cosgrove is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Investigating the Molecular Epidemiology of Extended-Spectrum β-Lactamase-Producing Enterobacterales (ESBL-E) Among Patients Admitted to the Intensive Care Unit 2025 ·Open Forum Infectious Diseases ·Sima L. Sharara, Patricia J. Simner, Yehudit Bergman, Emily Jacobs, (unknown), Eili Klein, Sara E. Cosgrove, Pranita D. Tamma	0
2	Using Encounter-Level Data for Risk-Adjustment of Antimicrobial Use Comparisons: Feasibility and Variable Selection 2025 ·Clinical Infectious Diseases ·Rebekah W. Moehring, (unknown), Elizabeth Dodds Ashley, Rachel Addison, Whitney R. Buckel, Sara E. Cosgrove, (unknown), Eili Klein, Carlos A.Q. Santos, Emily S Spivak, William E. Trick, Michael J. Smith, David J. Weber, Congwen Zhao, Deverick J. Anderson, Benjamin A. Goldstein	0
3	How to approach a patient hospitalized for pneumonia who is not responding to treatment? 2025 ·Intensive Care Medicine ·Pedro Póvoa, Luís Coelho, Jordi Carratalà, Kelly Cawcutt, Sara E. Cosgrove, Ricard Ferrer, Carlos A. Gómez, Michael Klompas, Thiago Lisboa, Ignacio Martín‐Loeches, Saad Nseir, Jorge I. Salluh, Sias Scherger, Daniel A. Sweeney, André C. Kalil	4
4	Impact of Blood Culture Contamination on Antibiotic Use, Resource Utilization, and Clinical Outcomes: A Retrospective Cohort Study in Dutch and US Hospitals 2023 ·Open Forum Infectious Diseases ·Michiel Schinkel, (unknown), Karen C. Carroll, Sara E. Cosgrove, Yea‐Jen Hsu, Eili Klein, Prabath W.B. Nanayakkara, Rogier P. Schade, W. Joost Wiersinga, Valeria Fabre	8
5	Which trial do we need? Early oral antibiotic therapy for the treatment of gram-negative bloodstream infections 2023 ·Clinical Microbiology and Infection ·Pranita D. Tamma, Sara E. Cosgrove	4
6	Healthcare personnel interactive pathogen exposure response system 2023 ·Infection Control and Hospital Epidemiology ·(unknown), (unknown), (unknown), (unknown), (unknown), Sara E. Cosgrove, Lisa L. Maragakis, Clare Rock, Eili Klein	0
7	Antibiotic Stewardship 2023 ·Infectious Disease Clinics of North America ·Sara E. Cosgrove, Arjun Srinivasan	8
8	Improving Sepsis Outcomes in the Era of Pay-for-Performance and Electronic Quality Measures: A Joint IDSA/ACEP/PIDS/SHEA/SHM/SIDP Position Paper 2023 ·Clinical Infectious Diseases ·Chanu Rhee, Jeffrey R. Strich, Kathleen Chiotos, David C. Classen, Sara E. Cosgrove, (unknown), Emily L. Heil, Sameer S. Kadri, André C. Kalil, David N. Gilbert, Henry Masur, Edward Septimus, Daniel A. Sweeney, (unknown), Dean L. Winslow, Donald M. Yealy, Michael Klompas	20
9	Adherence to Antimicrobial Prophylaxis Guidelines for Elective Surgeries Across 825 US Hospitals, 2019–2020 2023 ·Clinical Infectious Diseases ·Stephanie Cabral, Anthony Harris, Sara E. Cosgrove, Laurence S. Magder, Pranita D. Tamma, Katherine E Goodman	10
10	Controlling the chaos: Information management in home-infusion central-line–associated bloodstream infection (CLABSI) surveillance 2023 ·SHILAP Revista de lepidopterología ·Susan M. Hannum, (unknown), (unknown), (unknown), Jill A. Marsteller, Ayşe P. Gürses, Ilya Shpitser, Eili Klein, Sara E. Cosgrove, Sara C. Keller	2
11	Evaluating immunity to SARS‐CoV ‐2 in nursing home residents using saliva IgG 2022 ·Journal of the American Geriatrics Society ·Morgan J. Katz, Christopher D. Heaney, Nora Pisanic, (unknown), Benjamin F. Bigelow, (unknown), (unknown), Kate Kruczynski, Yea‐Jen Hsu, Alejandra Salinas, Sara E. Cosgrove, Clare Rock	6
12	Comparing the activity of novel antibiotic agents against carbapenem-resistant Enterobacterales clinical isolates 2022 ·Infection Control and Hospital Epidemiology ·Pranita D. Tamma, Yehudit Bergman, Emily Jacobs, Jae Hyoung Lee, Shawna Lewis, Sara E. Cosgrove, Patricia J. Simner	22
13	Administration of a β-Lactam Prior to Vancomycin as the First Dose of Antibiotic Therapy Improves Survival in Patients With Bloodstream Infections 2021 ·Clinical Infectious Diseases ·Joe Amoah, Eili Klein, Kathleen Chiotos, Sara E. Cosgrove, Pranita D. Tamma	12
14	The Voice of the Patient: Patient Roles in Antibiotic Management at the Hospital-to-Home Transition 2021 ·Journal of Patient Safety ·Sima L. Sharara, Alicia I. Arbaje, Sara E. Cosgrove, Ayşe P. Gürses, Kathryn Dzintars, (unknown), (unknown), Sara C. Keller	1
15	Electronically Available Patient Claims Data Improve Models for Comparing Antibiotic Use Across Hospitals: Results From 576 US Facilities 2020 ·Clinical Infectious Diseases ·Katherine E Goodman, Lisa Pineles, Laurence S. Magder, Deverick J. Anderson, Elizabeth Dodds Ashley, Ronald E. Polk, Hude Quan, William E. Trick, Keith F. Woeltje, Surbhi Leekha, Sara E. Cosgrove, Anthony D. Harris	14
16	Predicting probability of perirectal colonization with carbapenem-resistant Enterobacteriaceae (CRE) and other carbapenem-resistant organisms (CROs) at hospital unit admission 2019 ·Infection Control and Hospital Epidemiology ·Katherine E Goodman, Patricia J. Simner, Eili Klein, (unknown), (unknown), Matthew Toerper, Scott Levin, Pranita D. Tamma, Clare Rock, Sara E. Cosgrove, Lisa L. Maragakis, Aaron M. Milstone	33
17	Assessing burden of central line–associated bloodstream infections present on hospital admission 2019 ·American Journal of Infection Control ·(unknown), Sara E. Cosgrove, Deborah Williams, Sara C. Keller	5
18	How frequently are hospitalized patients colonized with carbapenem-resistant Enterobacteriaceae (CRE) already on contact precautions for other indications? 2018 ·Infection Control and Hospital Epidemiology ·Katherine E Goodman, Patricia J. Simner, Eili Klein, (unknown), (unknown), Clare Rock, Pranita D. Tamma, Sara E. Cosgrove, Lisa L. Maragakis, Aaron M. Milstone, (unknown)	12
19	Intraoperative Fraction of Inspired Oxygen Is a Modifiable Risk Factor for Surgical Site Infection after Spinal Surgery 2009 ·Anesthesiology ·Lisa L. Maragakis, Sara E. Cosgrove, Emilio A. Martı́nez, (unknown), David B. Cohen, Trish M. Perl	89
20	Poverty, health and participation. 2007 ·PubMed ·Sara E. Cosgrove	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact